DekaBank Deutsche Girozentrale
AKBA icon

DekaBank Deutsche Girozentrale’s Akebia Therapeutics AKBA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-102,100
Closed -$293K – 1419
2021
Q3 		$293K Hold
102,100
– – ﹤0.01% 1137
2021
Q2 		$390K Hold
102,100
– – ﹤0.01% 1113
2021
Q1 		$317K Hold
102,100
– – ﹤0.01% 1105
2020
Q4 		$279K Hold
102,100
– – ﹤0.01% 1132
2020
Q3 		$239K Buy
+102,100
New +$896K ﹤0.01% 1024
2019
Q4 		– Sell
-147,100
Closed -$606K – 1142
2019
Q3 		$606K Sell
147,100
-177,100
-55% -$759K ﹤0.01% 749
2019
Q2 		$1.5M Buy
324,200
+303,600
+1,474% +$1.73M 0.01% 698
2019
Q1 		$170K Buy
20,600
+3,500
+20% +$24K ﹤0.01% 1056
2018
Q4 		$95K Sell
17,100
-3,500
-17% -$27.4K ﹤0.01% 1063
2018
Q3 		$170K Hold
20,600
– – ﹤0.01% 1079
2018
Q2 		$193K Hold
20,600
– – ﹤0.01% 1051
2018
Q1 		$201K Buy
+20,600
New +$288K ﹤0.01% 990
2016
Q2 		– Sell
-17,000
Closed -$152K – 986
2016
Q1 		$152K Buy
17,000
+2,300
+16% +$18.6K ﹤0.01% 889
2015
Q4 		$187K Buy
14,700
+200
+1% +$2.04K ﹤0.01% 875
2015
Q3 		$140K Buy
14,500
+1,000
+7% +$9.18K ﹤0.01% 926
2015
Q2 		$139K Buy
13,500
+4,000
+42% +$34.1K ﹤0.01% 974
2015
Q1 		$106K Buy
+9,500
New +$101K ﹤0.01% 991

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AKBA Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Akebia Therapeutics (AKBA) in Q4 2021, closing a stake of 102,100 shares — an estimated $293K sold.

DekaBank Deutsche Girozentrale first reported a position in AKBA in Q1 2015 and held it in 17 quarters. The position peaked at $1.5M in Q2 2019. 133 funds tracked by Wall St. Rank hold AKBA as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Akebia Therapeutics position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 102,100 Akebia Therapeutics shares in Q4 2021, an estimated $293K.
  • DekaBank Deutsche Girozentrale first reported a position in Akebia Therapeutics in Q1 2015 and held it in 17 quarters.
  • DekaBank Deutsche Girozentrale's Akebia Therapeutics position peaked at $1.5M in Q2 2019.
  • 133 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.